Form 8-K - Current report:
SEC Accession No. 0000874716-25-000085
Filing Date
2025-05-09
Accepted
2025-05-09 16:00:15
Documents
17
Period of Report
2025-05-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-20250507.htm   iXBRL 8-K 62962
2 EX-3.1 exhibit31-idxxarcoi2025.htm EX-3.1 62292
3 EX-3.2 exhibit32-idxxarbyxlaws2025.htm EX-3.2 207526
8 idxx-20250507_g1.jpg GRAPHIC 47794
  Complete submission text file 0000874716-25-000085.txt   653918

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20250507.xsd EX-101.SCH 2127
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20250507_def.xml EX-101.DEF 15429
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20250507_lab.xml EX-101.LAB 27260
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20250507_pre.xml EX-101.PRE 16137
20 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20250507_htm.xml XML 2963
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 25930147
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)